-
Je něco špatně v tomto záznamu ?
Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus
L. Eyer, M. Šmídková, R. Nencka, J. Neča, T. Kastl, M. Palus, E. De Clercq, D. Růžek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-34238A
MZ0
CEP - Centrální evidence projektů
- MeSH
- antivirové látky chemie farmakologie MeSH
- buněčné linie MeSH
- klíšťová encefalitida farmakoterapie virologie MeSH
- molekulární struktura MeSH
- nukleosidy chemie farmakologie MeSH
- prasata MeSH
- replikace viru účinky léků MeSH
- viry klíšťové encefalitidy účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Tick-borne encephalitis (TBE) represents one of the most serious arboviral neuro-infections in Europe and northern Asia. As no specific antiviral therapy is available at present, there is an urgent need for efficient drugs to treat patients with TBE virus (TBEV) infection. Using two standardised in vitro assay systems, we evaluated a series of 29 nucleoside derivatives for their ability to inhibit TBEV replication in cell lines of neuronal as well as extraneural origin. The series of tested compounds included 2'-C- or 2'-O-methyl substituted nucleosides, 2'-C-fluoro-2'-C-methyl substituted nucleosides, 3'-O-methyl substituted nucleosides, 3'-deoxynucleosides, derivatives with 4'-C-azido substitution, heterobase modified nucleosides and neplanocins. Our data demonstrate a relatively stringent structure-activity relationship for modifications at the 2', 3', and 4' nucleoside positions. Whereas nucleoside derivatives with the methylation at the C2' position or azido modification at the C4'position exerted a strong TBEV inhibition activity (EC50 from 0.3 to 11.1 μM) and low cytotoxicity in vitro, substitutions of the O2' and O3' positions led to a complete loss of anti-TBEV activity (EC50 > 50 μM). Moreover, some structural modifications of the heterobase moiety resulted in a high increase of cytotoxicity in vitro. High antiviral activity and low cytotoxicity of C2' methylated or C4' azido substituted pharmacophores suggest that such compounds might represent promising candidates for further development of potential therapeutic agents in treating TBEV infection.
Department of Virology Veterinary Research Institute Hudcova 70 CZ 62100 Brno Czech Republic
Rega Institute for Medical Research KU Leuven Minderbroedersstraat 10 B 3000 Leuven Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017127
- 003
- CZ-PrNML
- 005
- 20230808135447.0
- 007
- ta
- 008
- 180515s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.antiviral.2016.07.018 $2 doi
- 035 __
- $a (PubMed)27476046
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Eyer, Luděk $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic. $7 xx0098551
- 245 10
- $a Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus / $c L. Eyer, M. Šmídková, R. Nencka, J. Neča, T. Kastl, M. Palus, E. De Clercq, D. Růžek,
- 520 9_
- $a Tick-borne encephalitis (TBE) represents one of the most serious arboviral neuro-infections in Europe and northern Asia. As no specific antiviral therapy is available at present, there is an urgent need for efficient drugs to treat patients with TBE virus (TBEV) infection. Using two standardised in vitro assay systems, we evaluated a series of 29 nucleoside derivatives for their ability to inhibit TBEV replication in cell lines of neuronal as well as extraneural origin. The series of tested compounds included 2'-C- or 2'-O-methyl substituted nucleosides, 2'-C-fluoro-2'-C-methyl substituted nucleosides, 3'-O-methyl substituted nucleosides, 3'-deoxynucleosides, derivatives with 4'-C-azido substitution, heterobase modified nucleosides and neplanocins. Our data demonstrate a relatively stringent structure-activity relationship for modifications at the 2', 3', and 4' nucleoside positions. Whereas nucleoside derivatives with the methylation at the C2' position or azido modification at the C4'position exerted a strong TBEV inhibition activity (EC50 from 0.3 to 11.1 μM) and low cytotoxicity in vitro, substitutions of the O2' and O3' positions led to a complete loss of anti-TBEV activity (EC50 > 50 μM). Moreover, some structural modifications of the heterobase moiety resulted in a high increase of cytotoxicity in vitro. High antiviral activity and low cytotoxicity of C2' methylated or C4' azido substituted pharmacophores suggest that such compounds might represent promising candidates for further development of potential therapeutic agents in treating TBEV infection.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antivirové látky $x chemie $x farmakologie $7 D000998
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a viry klíšťové encefalitidy $x účinky léků $7 D004669
- 650 _2
- $a klíšťová encefalitida $x farmakoterapie $x virologie $7 D004675
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a nukleosidy $x chemie $x farmakologie $7 D009705
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a replikace viru $x účinky léků $7 D014779
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šmídková, Markéta, $d 1974- $7 xx0226455 $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Fleming Sq. 2, CZ-16610 Prague, Czech Republic.
- 700 1_
- $a Nencka, Radim $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Fleming Sq. 2, CZ-16610 Prague, Czech Republic.
- 700 1_
- $a Neča, Jiří $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
- 700 1_
- $a Kastl, Tomáš $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
- 700 1_
- $a Palus, Martin $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, and Faculty of Science, University of South Bohemia, Branišovská 31, CZ-37005 České Budějovice, Czech Republic.
- 700 1_
- $a De Clercq, Erik $u Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
- 700 1_
- $a Růžek, Daniel, $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, and Faculty of Science, University of South Bohemia, Branišovská 31, CZ-37005 České Budějovice, Czech Republic. Electronic address: ruzekd@paru.cas.cz. $d 1981- $7 stk2008441707
- 773 0_
- $w MED00000480 $t Antiviral research $x 1872-9096 $g Roč. 133, č. - (2016), s. 119-29
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27476046 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20230808135444 $b ABA008
- 999 __
- $a ok $b bmc $g 1300751 $s 1013967
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 133 $c - $d 119-29 $e 20160728 $i 1872-9096 $m Antiviral research $n Antiviral Res $x MED00000480
- GRA __
- $a NV16-34238A $p MZ0
- LZP __
- $a Pubmed-20180515